A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies

por Rosskopf, Sandra, Leitner, Judith, Paster, Wolfgang, Morton, Laura T., Hagedoorn, Renate S., Steinberger, Peter, Heemskerk, Mirjam H.M.
Publicado 2018

MHC II tetramers visualize human CD4(+) T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

por Long, Heather M., Chagoury, Odette L., Leese, Alison M., Ryan, Gordon B., James, Eddie, Morton, Laura T., Abbott, Rachel J.M., Sabbah, Shereen, Kwok, William, Rickinson, Alan B.
Publicado 2013

Implementing Chief Resident Immersion Training (CRIT) in the Care of Older Adults: Overcoming Barriers and Promoting Facilitators

por Furman, Christian Davis, Wagner, Lori, Gomes, Josephine, Gopalraj, Rangaraj, Parker, B. Frank, Morton, Laura, Antimisiaris, Demetra, Neamtu, Daniela, Masroor, Sadaf, Martin-Galijatovic, Ramie, Cotton, Samantha, Shaw, M. Ann
Publicado 2018

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

por Morton, Laura T, Wachsmann, Tassilo L A, Meeuwsen, Miranda H, Wouters, Anne K, Remst, Dennis F G, van Loenen, Marleen M, Falkenburg, J H Frederik, Heemskerk, Mirjam H M
Publicado 2022

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )

por Huisman, Wesley, Gille, Ilse, van der Maarel, Lieve E, Hageman, Lois, Morton, Laura T, de Jong, Rob C M, Heemskerk, Mirjam H M, Amsen, Derk, Falkenburg, J H Frederik, Jedema, Inge
Publicado 2020

Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential

por van Amerongen, Rosa A., Morton, Laura T., Chaudhari, Umesh G., Remst, Dennis F.G., Hagedoorn, Renate S., van den Berg, Cathelijne W., Freund, Christian, Falkenburg, J.H. Frederik, Heemskerk, Mirjam H.M.
Publicado 2023